@article{assefaEfficacySafetyDifferent2023,
  title = {Efficacy and Safety of Different Regimens in the Treatment of Patients with Latent Tuberculosis Infection: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials},
  shorttitle = {Efficacy and Safety of Different Regimens in the Treatment of Patients with Latent Tuberculosis Infection},
  author = {Assefa, Dawit Getachew and Bedru, Ahmed and Zeleke, Eden Dagnachew and Negash, Solomon Emiru and Debela, Dejene Tolossa and Molla, Wondowsen and Mengistu, Nebiyu and Woldesenbet, Tigist Tekle and Bedane, Neway Fekede and Kajogoo, Violet Dismas and Atim, Mary Gorret and Manyazewal, Tsegahun},
  year = {2023},
  month = may,
  journal = {Archives of Public Health},
  volume = {81},
  number = {1},
  pages = {82},
  issn = {2049-3258},
  doi = {10.1186/s13690-023-01098-z},
  urldate = {2023-12-26},
  abstract = {Treatment of latent tuberculosis infection (LTBI) is effective in preventing progression to TB disease. This study aimed to synthesize available evidence on the efficacy, adherence, and safety of LTBI treatment in order to assist policymakers to design appropriate national treatment policies and treatment protocols.},
  keywords = {Network meta-analysis,Systematic review,Tuberculosis preventive therapy},
  file = {/Users/zach/Zotero/storage/H9GPMWGV/Assefa et al_2023_Efficacy and safety of different regimens in the treatment of patients with.pdf;/Users/zach/Zotero/storage/F7AVD7YF/s13690-023-01098-z.html}
}

@article{attaibiUpdatedModelDivisome2022,
  title = {An {{Updated Model}} of the {{Divisome}}: {{Regulation}} of the {{Septal Peptidoglycan Synthesis Machinery}} by the {{Divisome}}},
  shorttitle = {An {{Updated Model}} of the {{Divisome}}},
  author = {Attaibi, Mohamed and {den Blaauwen}, Tanneke},
  year = {2022},
  month = mar,
  journal = {International Journal of Molecular Sciences},
  volume = {23},
  number = {7},
  pages = {3537},
  issn = {1422-0067},
  doi = {10.3390/ijms23073537},
  abstract = {The synthesis of a peptidoglycan septum is a fundamental part of bacterial fission and is driven by a multiprotein dynamic complex called the divisome. FtsW and FtsI are essential proteins that synthesize the peptidoglycan septum and are controlled by the regulatory FtsBLQ subcomplex and the activator FtsN. However, their mode of regulation has not yet been uncovered in detail. Understanding this process in detail may enable the development of new compounds to combat the rise in antibiotic resistance. In this review, recent data on the regulation of septal peptidoglycan synthesis is summarized and discussed. Based on structural models and the collected data, multiple putative interactions within FtsWI and with regulators are uncovered. This elaborates on and supports an earlier proposed model that describes active and inactive conformations of the septal peptidoglycan synthesis complex that are stabilized by these interactions. Furthermore, a new model on the spatial organization of the newly synthesized peptidoglycan and the synthesis complex is presented. Overall, the updated model proposes a balance between several allosteric interactions that determine the state of septal peptidoglycan synthesis.},
  langid = {english},
  pmcid = {PMC8998562},
  pmid = {35408901},
  keywords = {Bacterial Proteins,Cell Wall,divisome,FtsBLQ,FtsEX,FtsN,FtsWI,FtsZ,interactions,Membrane Proteins,Peptidoglycan,peptidoglycan hydrolases,regulation,septal peptidoglycan},
  file = {/Users/zach/Zotero/storage/FV358L3Z/Attaibi and den Blaauwen - 2022 - An Updated Model of the Divisome Regulation of th.pdf}
}

@article{baekAccuratePredictionProtein2021,
  title = {Accurate Prediction of Protein Structures and Interactions Using a Three-Track Neural Network},
  author = {Baek, Minkyung and DiMaio, Frank and Anishchenko, Ivan and Dauparas, Justas and Ovchinnikov, Sergey and Lee, Gyu Rie and Wang, Jue and Cong, Qian and Kinch, Lisa N. and Schaeffer, R. Dustin and Mill{\'a}n, Claudia and Park, Hahnbeom and Adams, Carson and Glassman, Caleb R. and DeGiovanni, Andy and Pereira, Jose H. and Rodrigues, Andria V. and {van Dijk}, Alberdina A. and Ebrecht, Ana C. and Opperman, Diederik J. and Sagmeister, Theo and Buhlheller, Christoph and {Pavkov-Keller}, Tea and Rathinaswamy, Manoj K. and Dalwadi, Udit and Yip, Calvin K. and Burke, John E. and Garcia, K. Christopher and Grishin, Nick V. and Adams, Paul D. and Read, Randy J. and Baker, David},
  year = {2021},
  month = aug,
  journal = {Science},
  volume = {373},
  number = {6557},
  pages = {871--876},
  publisher = {American Association for the Advancement of Science},
  doi = {10/gk7nhq},
  urldate = {2021-11-22}
}

@article{baranowskiDreamMycobacterium2019,
  title = {The {{Dream}} of a {{Mycobacterium}}},
  author = {Baranowski, Catherine and Rego, E. Hesper and Rubin, Eric J.},
  year = {2019},
  month = apr,
  journal = {Microbiology Spectrum},
  volume = {7},
  number = {2},
  pages = {10.1128/microbiolspec.gpp3-0008-2018},
  publisher = {American Society for Microbiology},
  doi = {10.1128/microbiolspec.gpp3-0008-2018},
  urldate = {2024-02-26},
  abstract = {How do mycobacteria divide? Cell division has been studied extensively in the model rod-shaped bacteria Escherichia coli and Bacillus subtilis, but much less is understood about cell division in mycobacteria, a genus that includes the major human pathogens M. tuberculosis and M. leprae. In general, bacterial cell division requires the concerted effort of many proteins in both space and time to elongate the cell, replicate and segregate the chromosome, and construct and destruct the septum - processes which result in the creation of two new daughter cells. Here, we describe these distinct stages of cell division in B. subtilis and follow with the current knowledge in mycobacteria. As will become apparent, there are many differences between mycobacteria and B. subtilis in terms of both the broad outline of cell division and the molecular details. So, while the fundamental challenge of spatially and temporally organizing cell division is shared between these rod-shaped bacteria, they have solved these challenges in often vastly different ways.},
  file = {/Users/zach/Zotero/storage/DS4EF6TJ/Baranowski et al. - 2019 - The Dream of a Mycobacterium.pdf}
}

@article{brittonConformationalChangesEssential2023,
  title = {Conformational Changes in the Essential {{E}}. Coli Septal Cell Wall Synthesis Complex Suggest an Activation Mechanism},
  author = {Britton, Brooke M. and Yovanno, Remy A. and Costa, Sara F. and McCausland, Joshua and Lau, Albert Y. and Xiao, Jie and Hensel, Zach},
  year = {2023},
  month = jul,
  journal = {Nature Communications},
  volume = {14},
  number = {1},
  pages = {4585},
  publisher = {Nature Publishing Group},
  issn = {2041-1723},
  doi = {10.1038/s41467-023-39921-4},
  urldate = {2023-08-01},
  abstract = {The bacterial divisome is a macromolecular machine composed of more than 30 proteins that controls cell wall constriction during division. Here, we present a model of the structure and dynamics of the core complex of the E. coli divisome, supported by a combination of structure prediction, molecular dynamics simulation, single-molecule imaging, and mutagenesis. We focus on the septal cell wall synthase complex formed by FtsW and FtsI, and its regulators FtsQ, FtsL, FtsB, and FtsN. The results indicate extensive interactions in four regions in the periplasmic domains of the complex. FtsQ, FtsL, and FtsB support FtsI in an extended conformation, with the FtsI transpeptidase domain lifted away from the membrane through interactions among the C-terminal domains. FtsN binds between FtsI and FtsL in a region rich in residues with superfission (activating) and dominant negative (inhibitory) mutations. Mutagenesis experiments and simulations suggest that the essential domain of FtsN links FtsI and FtsL together, potentially modulating interactions between the anchor-loop of FtsI and the putative catalytic cavity of FtsW, thus suggesting a mechanism of how FtsN activates the cell wall synthesis activities of FtsW and FtsI.},
  copyright = {2023 The Author(s)},
  langid = {english},
  keywords = {Bacterial structural biology,Cell division,Cellular microbiology,Single-molecule biophysics},
  file = {/Users/zach/Zotero/storage/DD2Y4WGK/Britton et al. - 2023 - Conformational changes in the essential E. coli se.pdf}
}

@article{carabelliSARSCoV2VariantBiology2023,
  title = {{{SARS-CoV-2}} Variant Biology: Immune Escape, Transmission and Fitness},
  shorttitle = {{{SARS-CoV-2}} Variant Biology},
  author = {Carabelli, Alessandro M. and Peacock, Thomas P. and Thorne, Lucy G. and Harvey, William T. and Hughes, Joseph and {de Silva}, Thushan I. and Peacock, Sharon J. and Barclay, Wendy S. and {de Silva}, Thushan I. and Towers, Greg J. and Robertson, David L.},
  year = {2023},
  month = mar,
  journal = {Nature Reviews Microbiology},
  volume = {21},
  number = {3},
  pages = {162--177},
  publisher = {Nature Publishing Group},
  issn = {1740-1534},
  doi = {10.1038/s41579-022-00841-7},
  urldate = {2024-02-25},
  abstract = {In late 2020, after circulating for almost a year in the human population, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibited a major step change in its adaptation to humans. These highly mutated forms of SARS-CoV-2 had enhanced rates of transmission relative to previous variants and were termed `variants of concern' (VOCs). Designated Alpha, Beta, Gamma, Delta and Omicron, the VOCs emerged independently from one another, and in turn each rapidly became dominant, regionally or globally, outcompeting previous variants. The success of each VOC relative to the previously dominant variant was enabled by altered intrinsic functional properties of the virus and, to various degrees, changes to virus antigenicity conferring the ability to evade a primed immune response. The increased virus fitness associated with VOCs is the result of a complex interplay of virus biology in the context of changing human immunity due to both vaccination and prior infection. In this Review, we summarize the literature on the relative transmissibility and antigenicity of SARS-CoV-2 variants, the role of mutations at the furin spike cleavage site and of non-spike proteins, the potential importance of recombination to virus success, and SARS-CoV-2 evolution in the context of T cells, innate immunity and population immunity. SARS-CoV-2 shows a complicated relationship among virus antigenicity, transmission and virulence, which has unpredictable implications for the future trajectory and disease burden of COVID-19.},
  copyright = {2023 Springer Nature Limited},
  langid = {english},
  keywords = {Mutation,SARS-CoV-2,Viral genetics},
  file = {/Users/zach/Zotero/storage/RPFM94CI/Carabelli et al. - 2023 - SARS-CoV-2 variant biology immune escape, transmi.pdf}
}

@misc{cravenModelInteractionsFtsQLB2022,
  title = {A Model of the Interactions between the {{FtsQLB}} and the {{FtsWI}} Peptidoglycan Synthase Complex in Bacterial Cell Division},
  author = {Craven, Samuel J. and Condon, Samson G. F. and Senes, Alessandro},
  year = {2022},
  month = oct,
  primaryclass = {New Results},
  pages = {2022.10.30.514410},
  publisher = {bioRxiv},
  doi = {10.1101/2022.10.30.514410},
  urldate = {2022-11-08},
  abstract = {In Escherichia coli, an important step in the divisome assembly pathway is the recruitment of the essential cell wall synthase complex FtsWI to the division site through interactions with the regulatory FtsQLB complex. Here, we investigate a key aspect of this recruitment by characterizing the structural organization of the FtsL-FtsW interaction. Mutations in the cytoplasmic and transmembrane regions of the two proteins result in cell division defects and loss of FtsW localization to division sites. We use these in vivo results to help validate the predicted interfaces from an AlphaFold2 model for the entire FtsQLBWI complex. Given the consistency between the predicted FtsQLBWI model and our current understanding of the structure and function of the complex, we further remodeled it, seeking insight into the potential structural transitions that may lead to activation of the FtsWI complex and PG synthesis. The model suggests that FtsLB serves as a support for FtsI, placing its periplasmic domain in an extended and possibly active conformation but it is also compatible with a proposed compact and possibly inactive conformation. Additionally, we reconfigure the model into an Fts[QLBWI]2 diprotomeric state, which suggests that FtsLB may act as a central hub during assembly of the PG synthesis machinery. Finally, we propose a possible role for FtsQ in activation of this machinery, potentially by acting as a gatekeeper for the interaction between the FtsL AWI region and FtsI. We propose that this gatekeeping function depends on a hinge next to the FtsLB CCD region, which has implications for the mechanisms behind the FtsLB off/on transition that is central to cell division regulation.},
  archiveprefix = {bioRxiv},
  chapter = {New Results},
  copyright = {{\copyright} 2022, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), CC BY-NC 4.0, as described at http://creativecommons.org/licenses/by-nc/4.0/},
  langid = {english},
  keywords = {QLBWI},
  file = {/Users/zach/Zotero/storage/YZCBM3RB/Craven et al_2022_A model of the interactions between the FtsQLB and the FtsWI peptidoglycan.pdf;/Users/zach/Zotero/storage/JX3EEG3F/2022.10.30.html}
}

@article{daleQuantifyingRatesLate2021,
  title = {Quantifying the Rates of Late Reactivation Tuberculosis: A Systematic Review},
  shorttitle = {Quantifying the Rates of Late Reactivation Tuberculosis},
  author = {Dale, Katie D. and Karmakar, Malancha and Snow, Kathryn J. and Menzies, Dick and Trauer, James M. and Denholm, Justin T.},
  year = {2021},
  month = oct,
  journal = {The Lancet Infectious Diseases},
  volume = {21},
  number = {10},
  pages = {e303-e317},
  publisher = {Elsevier},
  issn = {1473-3099, 1474-4457},
  doi = {10.1016/S1473-3099(20)30728-3},
  urldate = {2023-12-26},
  langid = {english},
  pmid = {33891908},
  file = {/Users/zach/Zotero/storage/GPZSK9YT/Dale et al_2021_Quantifying the rates of late reactivation tuberculosis.pdf}
}

@article{dartoisAntituberculosisTreatmentStrategies2022,
  title = {Anti-Tuberculosis Treatment Strategies and Drug Development: Challenges and Priorities},
  shorttitle = {Anti-Tuberculosis Treatment Strategies and Drug Development},
  author = {Dartois, V{\'e}ronique A. and Rubin, Eric J.},
  year = {2022},
  month = nov,
  journal = {Nature Reviews Microbiology},
  volume = {20},
  number = {11},
  pages = {685--701},
  publisher = {Nature Publishing Group},
  issn = {1740-1534},
  doi = {10.1038/s41579-022-00731-y},
  urldate = {2023-01-29},
  abstract = {Despite two decades of intensified research to understand and cure tuberculosis disease, biological uncertainties remain and hamper progress. However, owing to collaborative initiatives including academia, the pharmaceutical industry and non-for-profit organizations, the drug candidate pipeline is promising. This exceptional success comes with the inherent challenge of prioritizing multidrug regimens for clinical trials and revamping trial designs to accelerate regimen development and capitalize on drug discovery breakthroughs. Most wanted are markers of progression from latent infection to active pulmonary disease, markers of drug response and predictors of relapse, in vitro tools to uncover synergies that translate clinically and animal models to reliably assess the treatment shortening potential of new regimens. In this Review, we highlight the benefits and challenges of `one-size-fits-all' regimens and treatment duration versus individualized therapy based on disease severity and host and pathogen characteristics, considering scientific and operational perspectives.},
  copyright = {2022 Springer Nature Limited},
  langid = {english},
  keywords = {Antimicrobials,Drug discovery,Microbiology,Policy and public health in microbiology},
  file = {/Users/zach/Zotero/storage/9E2DPFSB/Dartois_Rubin_2022_Anti-tuberculosis treatment strategies and drug development.pdf}
}

@misc{evansProteinComplexPrediction2022,
  title = {Protein Complex Prediction with {{AlphaFold-Multimer}}},
  author = {Evans, Richard and O'Neill, Michael and Pritzel, Alexander and Antropova, Natasha and Senior, Andrew and Green, Tim and {\v Z}{\'i}dek, Augustin and Bates, Russ and Blackwell, Sam and Yim, Jason and Ronneberger, Olaf and Bodenstein, Sebastian and Zielinski, Michal and Bridgland, Alex and Potapenko, Anna and Cowie, Andrew and Tunyasuvunakool, Kathryn and Jain, Rishub and Clancy, Ellen and Kohli, Pushmeet and Jumper, John and Hassabis, Demis},
  year = {2022},
  month = mar,
  primaryclass = {New Results},
  pages = {2021.10.04.463034},
  publisher = {bioRxiv},
  doi = {10.1101/2021.10.04.463034},
  urldate = {2022-11-20},
  abstract = {While the vast majority of well-structured single protein chains can now be predicted to high accuracy due to the recent AlphaFold [1] model, the prediction of multi-chain protein complexes remains a challenge in many cases. In this work, we demonstrate that an AlphaFold model trained specifically for multimeric inputs of known stoichiometry, which we call AlphaFold-Multimer, significantly increases accuracy of predicted multimeric interfaces over input-adapted single-chain AlphaFold while maintaining high intra-chain accuracy. On a benchmark dataset of 17 heterodimer proteins without templates (introduced in [2]) we achieve at least medium accuracy (DockQ [3] {$\geq$} 0.49) on 13 targets and high accuracy (DockQ {$\geq$} 0.8) on 7 targets, compared to 9 targets of at least medium accuracy and 4 of high accuracy for the previous state of the art system (an AlphaFold-based system from [2]). We also predict structures for a large dataset of 4,446 recent protein complexes, from which we score all non-redundant interfaces with low template identity. For heteromeric interfaces we successfully predict the interface (DockQ {$\geq$} 0.23) in 70\% of cases, and produce high accuracy predictions (DockQ {$\geq$} 0.8) in 26\% of cases, an improvement of +27 and +14 percentage points over the flexible linker modification of AlphaFold [4] respectively. For homomeric inter-faces we successfully predict the interface in 72\% of cases, and produce high accuracy predictions in 36\% of cases, an improvement of +8 and +7 percentage points respectively.},
  archiveprefix = {bioRxiv},
  chapter = {New Results},
  copyright = {{\copyright} 2022, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.},
  langid = {english},
  file = {/Users/zach/Zotero/storage/4Y5R5A5U/Evans et al_2022_Protein complex prediction with AlphaFold-Multimer.pdf;/Users/zach/Zotero/storage/7HI435EE/2021.10.04.html}
}

@article{goodsmithDisruptionTuberculosisMembrane2015,
  title = {Disruption of an {{M}}. Tuberculosis {{Membrane Protein Causes}} a {{Magnesium-dependent Cell Division Defect}} and {{Failure}} to {{Persist}} in {{Mice}}},
  author = {Goodsmith, Nichole and Guo, Xinzheng V. and Vandal, Omar H. and Vaubourgeix, Julien and Wang, Ruojun and Botella, H{\'e}l{\`e}ne and Song, Shuang and Bhatt, Kamlesh and Liba, Amir and Salgame, Padmini and Schnappinger, Dirk and Ehrt, Sabine},
  year = {2015},
  month = feb,
  journal = {PLoS Pathogens},
  volume = {11},
  number = {2},
  publisher = {Public Library of Science},
  doi = {10.1371/journal.ppat.1004645},
  urldate = {2022-03-10},
  abstract = {The identification of Mycobacterium tuberculosis genes necessary for persistence in vivo provides insight into bacterial biology as well as host defense strategies. We show that disruption of M. tuberculosis membrane protein PerM (Rv0955) resulted in ...},
  langid = {english},
  pmid = {25658098},
  file = {/Users/zach/Zotero/storage/3L39TLQH/Goodsmith et al. - 2015 - Disruption of an M. tuberculosis Membrane Protein .pdf;/Users/zach/Zotero/storage/EYY2Z7C5/PMC4450064.html}
}

@article{graveHighthroughputStrategyIdentification2022,
  title = {High-Throughput Strategy for Identification of {{Mycobacterium}} Tuberculosis Membrane Protein Expression Conditions Using Folding Reporter {{GFP}}},
  author = {Gr{\=a}ve, Krist{\=i}ne and Bennett, Matthew D. and H{\"o}gbom, Martin},
  year = {2022},
  month = oct,
  journal = {Protein Expression and Purification},
  volume = {198},
  pages = {106132},
  issn = {1096-0279},
  doi = {10.1016/j.pep.2022.106132},
  abstract = {Mycobacterium tuberculosis membrane protein biochemistry and structural biology studies are often hampered by challenges in protein expression and selection for well-expressing protein candidates, suitable for further investigation. Here we present a folding reporter GFP (frGFP) assay, adapted for M. tuberculosis membrane protein screening in Escherichia coli Rosetta 2 (DE3) and Mycobacterium smegmatis mc24517. This method allows protein expression condition screening for multiple protein targets simultaneously by monitoring frGFP fluorescence in growing cells. We discuss the impact of common protein expression conditions on 42 essential M. tuberculosis H37Rv helical transmembrane proteins and establish the grounds for their further analysis. We have found that the basal expression of the lac operon in the T7-promoter expression system generally leads to high recombinant protein yield in M. smegmatis, and we suggest that a screening condition without the inducer is included in routine protein expression tests. In addition to the general observations, we describe conditions allowing high-level expression of more than 25 essential M. tuberculosis membrane proteins, containing 2 to 13 transmembrane helices. We hope that these findings will stimulate M. tuberculosis membrane protein research and aid the efforts in drug development against tuberculosis.},
  langid = {english},
  pmid = {35750296},
  keywords = {Bacterial Proteins,Expression optimization,Expression screening,Green Fluorescent Proteins,High-throughput,In-gel fluorescence,Membrane Proteins,Mycobacterium smegmatis,Mycobacterium tuberculosis,Promoter Regions Genetic,Recombinant proteins},
  file = {/Users/zach/Zotero/storage/JKG8JR6P/S1046592822000894.html}
}

@article{houbenGlobalBurdenLatent2016,
  title = {The {{Global Burden}} of {{Latent Tuberculosis Infection}}: {{A Re-estimation Using Mathematical Modelling}}},
  shorttitle = {The {{Global Burden}} of {{Latent Tuberculosis Infection}}},
  author = {Houben, Rein M. G. J. and Dodd, Peter J.},
  year = {2016},
  month = oct,
  journal = {PLOS Medicine},
  volume = {13},
  number = {10},
  pages = {e1002152},
  publisher = {Public Library of Science},
  issn = {1549-1676},
  doi = {10.1371/journal.pmed.1002152},
  urldate = {2023-12-24},
  abstract = {Background The existing estimate of the global burden of latent TB infection (LTBI) as ``one-third'' of the world population is nearly 20 y old. Given the importance of controlling LTBI as part of the End TB Strategy for eliminating TB by 2050, changes in demography and scientific understanding, and progress in TB control, it is important to re-assess the global burden of LTBI. Methods and Findings We constructed trends in annual risk in infection (ARI) for countries between 1934 and 2014 using a combination of direct estimates of ARI from LTBI surveys (131 surveys from 1950 to 2011) and indirect estimates of ARI calculated from World Health Organisation (WHO) estimates of smear positive TB prevalence from 1990 to 2014. Gaussian process regression was used to generate ARIs for country-years without data and to represent uncertainty. Estimated ARI time-series were applied to the demography in each country to calculate the number and proportions of individuals infected, recently infected (infected within 2 y), and recently infected with isoniazid (INH)-resistant strains. Resulting estimates were aggregated by WHO region. We estimated the contribution of existing infections to TB incidence in 2035 and 2050. In 2014, the global burden of LTBI was 23.0\% (95\% uncertainty interval [UI]: 20.4\%--26.4\%), amounting to approximately 1.7 billion people. WHO South-East Asia, Western-Pacific, and Africa regions had the highest prevalence and accounted for around 80\% of those with LTBI. Prevalence of recent infection was 0.8\% (95\% UI: 0.7\%--0.9\%) of the global population, amounting to 55.5 (95\% UI: 48.2--63.8) million individuals currently at high risk of TB disease, of which 10.9\% (95\% UI:10.2\%--11.8\%) was isoniazid-resistant. Current LTBI alone, assuming no additional infections from 2015 onwards, would be expected to generate TB incidences in the region of 16.5 per 100,000 per year in 2035 and 8.3 per 100,000 per year in 2050. Limitations included the quantity and methodological heterogeneity of direct ARI data, and limited evidence to inform on potential clearance of LTBI. Conclusions We estimate that approximately 1.7 billion individuals were latently infected with Mycobacterium tuberculosis (M.tb) globally in 2014, just under a quarter of the global population. Investment in new tools to improve diagnosis and treatment of those with LTBI at risk of progressing to disease is urgently needed to address this latent reservoir if the 2050 target of eliminating TB is to be reached.},
  langid = {english},
  keywords = {Africa,Age groups,Antibiotic resistance,Asia,Epidemiology,Medical risk factors,Mycobacterium tuberculosis,Tuberculosis}
}

@article{jainDelineatingFtsQmediatedRegulation2018,
  title = {Delineating {{FtsQ-mediated}} Regulation of Cell Division in {{{\emph{Mycobacterium}}}}{\emph{ Tuberculosis}}},
  author = {Jain, Preeti and Malakar, Basanti and Khan, Mehak Zahoor and Lochab, Savita and Singh, Archana and Nandicoori, Vinay Kumar},
  year = {2018},
  month = aug,
  journal = {Journal of Biological Chemistry},
  volume = {293},
  number = {32},
  pages = {12331--12349},
  issn = {0021-9258},
  doi = {10.1074/jbc.RA118.003628},
  urldate = {2024-02-26},
  abstract = {Identifying and characterizing the individual contributors to bacterial cellular elongation and division will improve our understanding of their impact on cell growth and division. Here, we delineated the role of ftsQ, a terminal gene of the highly conserved division cell wall (dcw) operon, in growth, survival, and cell length maintenance in the human pathogen Mycobacterium tuberculosis (Mtb). We found that FtsQ overexpression significantly increases the cell length and number of multiseptate cells. FtsQ depletion in Mtb resulted in cells that were shorter than WT cells during the initial growth stages (4 days after FtsQ depletion) but were longer than WT cells at later stages (10 days after FtsQ depletion) and compromised the survival in vitro and in differentiated THP1 macrophages. Overexpression of N- and C-terminal FtsQ regions altered the cell length, and the C-terminal domain alone complemented the FtsQ depletion phenotype. MS analyses suggested robust FtsQ phosphorylation on Thr-24, and although phosphoablative and -mimetic mutants rescued the FtsQ depletion--associated cell viability defects, they failed to complement the cell length defects. MS and coimmunoprecipitation experiments identified 63 FtsQ-interacting partners, and we show that the interaction of FtsQ with the recently identified cell division protein SepIVA is independent of FtsQ phosphorylation and suggests a role of FtsQ in modulating cell division. FtsQ exhibited predominantly septal localization in both the presence and absence of SepIVA. Our results suggest a role for FtsQ in modulating the length, division, and survival of Mtb cells both in vitro and in the host.},
  keywords = {cell division,dcw operon,divisome,FtsQ,mycobacteria,Mycobacterium tuberculosis,phosphorylation,protein kinase,regulation,septation},
  file = {/Users/zach/Zotero/storage/MLZY57UH/Jain et al. - 2018 - Delineating FtsQ-mediated regulation of cell divis.pdf;/Users/zach/Zotero/storage/9TKWM2YM/S0021925820313569.html}
}

@article{kashammerCryoEMStructureBacterial2023,
  title = {Cryo-{{EM}} Structure of the Bacterial Divisome Core Complex and Antibiotic Target {{FtsWIQBL}}},
  author = {K{\"a}shammer, Lisa and {van den Ent}, Fusinita and Jeffery, Magnus and Jean, Nicolas L. and Hale, Victoria L. and L{\"o}we, Jan},
  year = {2023},
  month = may,
  journal = {Nature Microbiology},
  pages = {1--11},
  publisher = {Nature Publishing Group},
  issn = {2058-5276},
  doi = {10.1038/s41564-023-01368-0},
  urldate = {2023-05-08},
  abstract = {In most bacteria, cell division relies on the synthesis of new cell wall material by the multiprotein divisome complex. Thus, at the core of the divisome are the transglycosylase FtsW, which synthesises peptidoglycan strands from its substrate Lipid II, and the transpeptidase FtsI that cross-links these strands to form a mesh, shaping and protecting the bacterial cell. The FtsQ--FtsB--FtsL trimeric complex interacts with the FtsWI complex and is involved in regulating its enzymatic activities; however, the structure of this pentameric complex is unknown. Here, we present the cryogenic electron microscopy structure of the FtsWIQBL complex from Pseudomonas aeruginosa at 3.7\,{\AA} resolution. Our work reveals intricate structural details, including an extended coiled coil formed by FtsL and FtsB and the periplasmic interaction site between FtsL and FtsI. Our structure explains the consequences of previously reported mutations and we postulate a possible activation mechanism involving a large conformational change in the periplasmic domain. As FtsWIQBL is central to the divisome, our structure is foundational for the design of future experiments elucidating the precise mechanism of bacterial cell division, an important antibiotic target.},
  copyright = {2023 The Author(s), under exclusive licence to Springer Nature Limited},
  langid = {english},
  keywords = {Bacterial structural biology,Cell Cycle Proteins,Cell division,Cryoelectron microscopy,Cryoelectron Microscopy,Escherichia coli,Escherichia coli Proteins,Membrane Proteins},
  file = {/Users/zach/Zotero/storage/GTE5QNLV/KÃ¤shammer et al_2023_Cryo-EM structure of the bacterial divisome core complex and antibiotic target.pdf}
}

@article{korepanovaCloningExpressionMultiple2005,
  title = {Cloning and Expression of Multiple Integral Membrane Proteins from {{Mycobacterium}} Tuberculosis in {{Escherichia}} Coli},
  author = {Korepanova, Alla and Gao, Fei P. and Hua, Yuanzi and Qin, Huajun and Nakamoto, Robert K. and Cross, Timothy A.},
  year = {2005},
  month = jan,
  journal = {Protein Science : A Publication of the Protein Society},
  volume = {14},
  number = {1},
  pages = {148--158},
  issn = {0961-8368},
  doi = {2023101017072700228},
  urldate = {2023-10-30},
  abstract = {Seventy integral membrane proteins from the Mycobacterium tuberculosis genome have been cloned and expressed in Escherichia coli. A combination of T7 promoter-based vectors with hexa-His affinity tags and BL21 E. coli strains with additional tRNA genes to supplement sparsely used E. coli codons have been most successful. The expressed proteins have a wide range of molecular weights and number of transmembrane helices. Expression of these proteins has been observed in the membrane and insoluble fraction of E. coli cell lysates and, in some cases, in the soluble fraction. The highest expression levels in the membrane fraction were restricted to a narrow range of molecular weights and relatively few transmembrane helices. In contrast, overexpression in insoluble aggregates was distributed over a broad range of molecular weights and number of transmembrane helices.},
  pmcid = {PMC2253320},
  pmid = {15608119},
  keywords = {cloning,Escherichia coli,membrane protein,membrane protein expression,Mycobacterium tuberculosis,structural genomics},
  file = {/Users/zach/Zotero/storage/7W9I8VZR/Korepanova et al_2005_Cloning and expression of multiple integral membrane proteins from.pdf;/Users/zach/Zotero/storage/APDY4RFE/Korepanova et al_2005_Cloning and expression of multiple integral membrane proteins from.pdf;/Users/zach/Zotero/storage/5RMAAES7/ps.html}
}

@article{liAcquiredResistanceIsoniazid2021,
  title = {Acquired {{Resistance}} to {{Isoniazid During Isoniazid Monotherapy}} in a {{Subject}} with {{Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact}}: {{A Case Report}}},
  shorttitle = {Acquired {{Resistance}} to {{Isoniazid During Isoniazid Monotherapy}} in a {{Subject}} with {{Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact}}},
  author = {Li, Tsung-Lun and Chan, Tai-Hua and Wang, Cheng-Hui and Jou, Ruwen and Yu, Ming-Chih and Putri, Denise Utami and Lee, Chih-Hsin and Lin, Yi-Hsien},
  year = {2021},
  month = apr,
  journal = {Infection and Drug Resistance},
  volume = {14},
  pages = {1505--1509},
  issn = {1178-6973},
  doi = {10.2147/IDR.S304799},
  urldate = {2023-12-26},
  abstract = {Appropriate treatment is the key element in eliminating tuberculosis (TB), and requires prompt diagnosis. We presented a case of a household contact of rifampicin-resistant TB revealing reactive IFN-gamma release assay with unsuspicious clinical and radiologic examinations. She was diagnosed with latent tuberculosis infection (LTBI) and treated with isoniazid monotherapy. On the ninth month, she developed a progressive cough and was found to harbor active TB disease with added resistance to isoniazid. An individualized anti-TB regimen consisting of moxifloxacin, kanamycin, prothionamide, ethambutol, and pyrazinamide was prescribed for 20 months, leading to sputum culture conversion and improvement of the reported symptom. No recurrence was observed on one-year follow-up. Assuming high compliance to therapy, we propose that the patient may have been underdiagnosed and received sub-optimal treatment leading to acquired-drug resistance. Conventional diagnosis methods based on immunological assay and radiographical findings may be insufficient to distinguish the incipient and subclinical states of TB from LTBI.},
  pmcid = {PMC8068479},
  pmid = {33907428},
  file = {/Users/zach/Zotero/storage/L3S6QECC/Li et al_2021_Acquired Resistance to Isoniazid During Isoniazid Monotherapy in a Subject with.pdf}
}

@article{lucenaMicrodomainFormationGeneral2018,
  title = {Microdomain Formation Is a General Property of Bacterial Membrane Proteins and Induces Heterogeneity of Diffusion Patterns},
  author = {Lucena, Daniella and Mauri, Marco and Schmidt, Felix and Eckhardt, Bruno and Graumann, Peter L.},
  year = {2018},
  month = sep,
  journal = {BMC Biology},
  volume = {16},
  number = {1},
  pages = {97},
  issn = {1741-7007},
  doi = {10.1186/s12915-018-0561-0},
  urldate = {2024-03-05},
  abstract = {Proteins within the cytoplasmic membrane display distinct localization patterns and arrangements. While multiple models exist describing the dynamics of membrane proteins, to date, there have been few systematic studies, particularly in bacteria, to evaluate how protein size, number of transmembrane domains, and temperature affect their diffusion, and if conserved localization patterns exist.},
  langid = {english},
  keywords = {B. subtilis,Diffusion,Membrane dynamics,Membrane protein localization,Single-molecule tracking},
  file = {/Users/zach/Zotero/storage/K82LBKIM/Lucena et al. - 2018 - Microdomain formation is a general property of bac.pdf}
}

@article{meadeGenomewideScreenIdentifies2023,
  title = {Genome-Wide Screen Identifies Host Loci That Modulate {{Mycobacterium}} Tuberculosis Fitness in Immunodivergent Mice},
  author = {Meade, Rachel K and Long, Jarukit E and Jinich, Adrian and Rhee, Kyu Y and Ashbrook, David G and Williams, Robert W and Sassetti, Christopher M and Smith, Clare M},
  year = {2023},
  month = sep,
  journal = {G3 Genes{\textbar}Genomes{\textbar}Genetics},
  volume = {13},
  number = {9},
  pages = {jkad147},
  issn = {2160-1836},
  doi = {10.1093/g3journal/jkad147},
  urldate = {2023-12-19},
  abstract = {Genetic differences among mammalian hosts and among strains of Mycobacterium tuberculosis (Mtb) are well-established determinants of tuberculosis (TB) patient outcomes. The advent of recombinant inbred mouse panels and next-generation transposon mutagenesis and sequencing approaches has enabled dissection of complex host--pathogen interactions. To identify host and pathogen genetic determinants of Mtb pathogenesis, we infected members of the highly diverse BXD family of strains with a comprehensive library of Mtb transposon mutants (TnSeq). Members of the BXD family segregate for Mtb-resistant C57BL/6J (B6 or B) and Mtb-susceptible DBA/2J (D2 or D) haplotypes. The survival of each bacterial mutant was quantified within each BXD host, and we identified those bacterial genes that were differentially required for Mtb fitness across BXD genotypes. Mutants that varied in survival among the host family of strains were leveraged as reporters of ``endophenotypes,'' each bacterial fitness profile directly probing specific components of the infection microenvironment. We conducted quantitative trait loci (QTL) mapping of these bacterial fitness endophenotypes and identified 140 host--pathogen QTL (hpQTL). We located a QTL hotspot on chromosome 6 (75.97--88.58 Mb) associated with the genetic requirement of multiple Mtb genes: Rv0127 (mak), Rv0359 (rip2), Rv0955 (perM), and Rv3849 (espR). Together, this screen reinforces the utility of bacterial mutant libraries as precise reporters of the host immunological microenvironment during infection and highlights specific host--pathogen genetic interactions for further investigation. To enable downstream follow-up for both bacterial and mammalian genetic research communities, all bacterial fitness profiles have been deposited into GeneNetwork.org and added into the comprehensive collection of TnSeq libraries in MtbTnDB.},
  file = {/Users/zach/Zotero/storage/THSUCU72/Meade et al_2023_Genome-wide screen identifies host loci that modulate Mycobacterium.pdf;/Users/zach/Zotero/storage/AED8NWD8/7219625.html}
}

@misc{parkEssentialDomainFtsN2023,
  title = {The Essential Domain of {{FtsN}} Triggers Cell Division by Promoting Interaction between {{FtsL}} and {{FtsI}}},
  author = {Park, Kyung-Tae and Park, David Johnson and Pichoff, Sebastien and Du, Shishen and Lutkenhaus, Joe},
  year = {2023},
  month = may,
  primaryclass = {New Results},
  pages = {2023.05.12.540521},
  publisher = {bioRxiv},
  doi = {10.1101/2023.05.12.540521},
  urldate = {2023-11-27},
  abstract = {Cell division in bacteria requires the activation of FtsWI at the division site to synthesize septal peptidoglycan. In E. coli FtsN activates FtsWI and a previous model posited that the essential domain of FtsN (EFtsN) acts on FtsQLB causing conformational changes so that a domain of FtsL, called AWI (AWIFtsL), contacts FtsI resulting in activation of FtsW. In this study we use genetic analysis along with an AlphaFold2 model to test this activation model. Based on our findings we propose an updated model wherein the AWIFtsL and FtsI interaction is stabilized by EFtsN to activate FtsW and that this interaction is enhanced by the CytoFtsN-FtsA interaction. Thus, FtsN acts as both a sensor for divisome assembly and an activator. In addition, we elucidate the role played by two critical FtsL residues in FtsW activation.},
  archiveprefix = {bioRxiv},
  chapter = {New Results},
  copyright = {{\copyright} 2023, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.},
  langid = {english},
  file = {/Users/zach/Zotero/storage/W2W25JGT/Park et al_2023_The essential domain of FtsN triggers cell division by promoting interaction.pdf}
}

@article{paulussenCovalentProteomimeticInhibitor2022,
  title = {Covalent {{Proteomimetic Inhibitor}} of the {{Bacterial FtsQB Divisome Complex}}},
  author = {Paulussen, Felix M. and Schouten, Gina K. and Moertl, Carolin and Verheul, Jolanda and Hoekstra, Irma and Koningstein, Gregory M. and Hutchins, George H. and Alkir, Aslihan and Luirink, Rosa A. and Geerke, Daan P. and {van Ulsen}, Peter and {den Blaauwen}, Tanneke and Luirink, Joen and Grossmann, Tom N.},
  year = {2022},
  month = aug,
  journal = {Journal of the American Chemical Society},
  volume = {144},
  number = {33},
  pages = {15303--15313},
  publisher = {American Chemical Society},
  issn = {0002-7863},
  doi = {10.1021/jacs.2c06304},
  urldate = {2023-01-26},
  abstract = {The use of antibiotics is threatened by the emergence and spread of multidrug-resistant strains of bacteria. Thus, there is a need to develop antibiotics that address new targets. In this respect, the bacterial divisome, a multi-protein complex central to cell division, represents a potentially attractive target. Of particular interest is the FtsQB subcomplex that plays a decisive role in divisome assembly and peptidoglycan biogenesis in E. coli. Here, we report the structure-based design of a macrocyclic covalent inhibitor derived from a periplasmic region of FtsB that mediates its binding to FtsQ. The bioactive conformation of this motif was stabilized by a customized cross-link resulting in a tertiary structure mimetic with increased affinity for FtsQ. To increase activity, a covalent handle was incorporated, providing an inhibitor that impedes the interaction between FtsQ and FtsB irreversibly. The covalent inhibitor reduced the growth of an outer membrane-permeable E. coli strain, concurrent with the expected loss of FtsB localization, and also affected the infection of zebrafish larvae by a clinical E. coli strain. This first-in-class inhibitor of a divisome protein--protein interaction highlights the potential of proteomimetic molecules as inhibitors of challenging targets. In particular, the covalent mode-of-action can serve as an inspiration for future antibiotics that target protein--protein interactions.},
  file = {/Users/zach/Zotero/storage/73ZHYYPW/Paulussen et al_2022_Covalent Proteomimetic Inhibitor of the Bacterial FtsQB Divisome Complex.pdf;/Users/zach/Zotero/storage/YHDL62CK/jacs.html}
}

@article{regoDeletionMycobacterialDivisome2017,
  title = {Deletion of a Mycobacterial Divisome Factor Collapses Single-Cell Phenotypic Heterogeneity},
  shorttitle = {Deletion of a Mycobacterial Divisome Factor Collapses Single-Cell Phenotypic Heterogeneity},
  author = {Rego, E. H. and Audette, R. E. and Rubin, E. J.},
  year = {2017},
  month = jun,
  journal = {Nature},
  volume = {546},
  number = {7656},
  pages = {153--157},
  issn = {1476-4687 (Electronic) 0028-0836 (Linking)},
  doi = {10/f98xxz},
  abstract = {Microorganisms are often studied as populations but the behaviour of single, individual cells can have important consequences. For example, tuberculosis, caused by the bacterial pathogen Mycobacterium tuberculosis, requires months of antibiotic therapy even though the bulk of the bacterial population dies rapidly. Shorter courses lead to high rates of relapse because subpopulations of bacilli can survive despite being genetically identical to those that are easily killed. In fact, mycobacteria create variability each time a cell divides, producing daughter cells with different sizes and growth rates. The mechanism(s) that underlie this high-frequency variation and how variability relates to survival of the population are unknown. Here we show that mycobacteria actively create heterogeneity. Using a fluorescent reporter and a fluorescence-activated cell sorting (FACS)-based transposon screen, we find that deletion of lamA, a gene of previously unknown function, decreases heterogeneity in the population by decreasing asymmetric polar growth. LamA has no known homologues in other organisms, but is highly conserved across mycobacterial species. We find that LamA is a member of the mycobacterial division complex (the 'divisome'). It inhibits growth at nascent new poles, creating asymmetry in polar growth. The kinetics of killing individual cells that lack lamA are more uniform and more rapid with rifampicin and drugs that target the cell wall. Our results show that mycobacteria encode a non-conserved protein that controls the pattern of cell growth, resulting in a population that is both heterogeneous and better able to survive antibiotic pressure.},
  keywords = {Bacterial genes,Bacteriology,Pathogens,Time-lapse imaging},
  file = {/Users/zach/Zotero/storage/DDJH466S/Rego et al_2017_Deletion of a mycobacterial divisome factor collapses single-cell phenotypic.pdf;/Users/zach/Zotero/storage/NNEK5564/Rego et al. - 2017 - Deletion of a mycobacterial divisome factor collap.pdf}
}

@article{silvaPlasmidsIndependentlyTunable2019,
  title = {Plasmids for {{Independently Tunable}}, {{Low-Noise Expression}} of {{Two Genes}}},
  author = {Silva, Jo{\~a}o P. N. and Lopes, Soraia Vidigal and Grilo, Diogo J. and Hensel, Zach},
  year = {2019},
  month = jun,
  journal = {mSphere},
  volume = {4},
  number = {3},
  publisher = {American Society for Microbiology Journals},
  issn = {2379-5042},
  doi = {10/gf3vhf},
  urldate = {2020-04-28},
  abstract = {Some microbiology experiments and biotechnology applications can be improved if it is possible to tune the expression of two different genes at the same time with cell-to-cell variation at or below the level of genes constitutively expressed from the chromosome (the ``extrinsic noise limit''). This was recently achieved for a single gene by exploiting negative autoregulation by the tetracycline repressor (TetR) and bicistronic gene expression to reduce gene expression noise. We report new plasmids that use the same principles to achieve simultaneous, low-noise expression for two genes in Escherichia coli. The TetR system was moved to a compatible plasmid backbone, and a system based on the lac repressor (LacI) was found to also exhibit gene expression noise below the extrinsic noise limit. We characterized gene expression mean and noise across the range of induction levels for these plasmids, applied the LacI system to tune expression for single-molecule mRNA detection under two different growth conditions, and showed that two plasmids can be cotransformed to independently tune expression of two different genes. IMPORTANCE Microbiologists often express foreign proteins in bacteria in order study them or to use bacteria as a microbial factory. Usually, this requires controlling the number of foreign proteins expressed in each cell, but for many common protein expression systems, it is difficult to ``tune'' protein expression without large cell-to-cell variation in expression levels (called ``noise'' in protein expression). This work describes two protein expression systems that can be combined in the same cell, with tunable expression levels and very low protein expression noise. One new system was used to detect single mRNA molecules by fluorescence microscopy, and the two systems were shown to be independent of each other. These protein expression systems may be useful in any experiment or biotechnology application that can be improved with low protein expression noise.},
  chapter = {Resource Report},
  copyright = {Copyright {\copyright} 2019 Silva et al.. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.},
  langid = {english},
  pmid = {31142623},
  file = {/Users/zach/Zotero/storage/BCU5CJ6Q/515940.html;/Users/zach/Zotero/storage/XGZ3YYQE/e00340-19.html;/Users/zach/Zotero/storage/ZX9YVLTP/e00340-19.html}
}

@article{vandalMembraneProteinPreserves2008,
  title = {A Membrane Protein Preserves Intrabacterial {{pH}} in Intraphagosomal {{Mycobacterium}} Tuberculosis},
  author = {Vandal, Omar H. and Pierini, Lynda M. and Schnappinger, Dirk and Nathan, Carl F. and Ehrt, Sabine},
  year = {2008},
  month = aug,
  journal = {Nature medicine},
  volume = {14},
  number = {8},
  pages = {849},
  publisher = {NIH Public Access},
  doi = {10.1038/nmXXXX},
  urldate = {2022-03-10},
  abstract = {Acidification of the phagosome is considered to be a major mechanism used by macrophages against bacteria, including Mycobacterium tuberculosis (Mtb). Mtb blocks phagosome acidification, but interferon-{$\gamma$} (IFN-{$\gamma$}) restores acidification ...},
  langid = {english},
  pmid = {18641659},
  keywords = {Invalid DOI},
  file = {/Users/zach/Zotero/storage/Z6RBNWWH/Vandal et al_2008_A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium.pdf;/Users/zach/Zotero/storage/3XBMVZ57/PMC2538620.html}
}

@article{wangPersistentMycobacteriumTuberculosis2019,
  title = {Persistent {{Mycobacterium}} Tuberculosis Infection in Mice Requires {{PerM}} for Successful Cell Division},
  author = {Wang, Ruojun and Kreutzfeldt, Kaj and Botella, Helene and Vaubourgeix, Julien and Schnappinger, Dirk and Ehrt, Sabine},
  editor = {Garrett, Wendy S and Kana, Bavesh D and Boutte, Cara and Rego, E Hesper},
  year = {2019},
  month = nov,
  journal = {eLife},
  volume = {8},
  pages = {e49570},
  publisher = {eLife Sciences Publications, Ltd},
  issn = {2050-084X},
  doi = {10.7554/eLife.49570},
  urldate = {2022-03-09},
  abstract = {The ability of Mycobacterium tuberculosis (Mtb) to persist in its host is central to the pathogenesis of tuberculosis, yet the underlying mechanisms remain incompletely defined. PerM, an integral membrane protein, is required for persistence of Mtb in mice. Here, we show that perM deletion caused a cell division defect specifically during the chronic phase of mouse infection, but did not affect Mtb's cell replication during acute infection. We further demonstrate that PerM is required for cell division in chronically infected mice and in vitro under host-relevant stresses because it is part of the mycobacterial divisome and stabilizes the essential divisome protein FtsB. These data highlight the importance of sustained cell division for Mtb persistence, define condition-specific requirements for cell division and reveal that survival of Mtb during chronic infection depends on a persistence divisome.},
  keywords = {cell division,chronic infection,Mycobacterium tuberculosis,persistence},
  file = {/Users/zach/Zotero/storage/QJPZ4KDS/Wang et al. - 2019 - Persistent Mycobacterium tuberculosis infection in.pdf;/Users/zach/Zotero/storage/X7R3V3R9/Wang et al. - 2019 - Persistent Mycobacterium tuberculosis infection in.pdf;/Users/zach/Zotero/storage/589BFYQ4/PMC6872210.html}
}

@techreport{whoLatentTuberculosisInfection2018,
  title = {Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management},
  shorttitle = {Latent Tuberculosis Infection},
  author = {WHO},
  year = {2018},
  urldate = {2023-12-24},
  abstract = {These new guidelines supersede previous WHO policy documents on the management of LTBI in people living with HIV, household contacts of people with active TB, other groups at risk of developing TB, and for LTBI testing. The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The guidelines are to be used primarily in national TB and HIV control programmes, or their equivalents in ministries of health, and for other policy-makers working on TB and HIV and infectious diseases. They are also appropriate for officials in other line ministries with work in the areas of health.},
  langid = {english},
  file = {/Users/zach/Zotero/storage/UBZIL829/Latent tuberculosis infection updated and consoli.pdf;/Users/zach/Zotero/storage/JL3BJYJV/9789241550239.html}
}

@article{wuCharacterizationConservedNovel2018,
  title = {Characterization of {{Conserved}} and {{Novel Septal Factors}} in {{Mycobacterium}} Smegmatis},
  author = {Wu, Katherine J. and Zhang, Jenna and Baranowski, Catherine and Leung, Vivian and Rego, E. Hesper and Morita, Yasu S. and Rubin, Eric J. and Boutte, Cara C.},
  year = {2018},
  month = feb,
  journal = {Journal of Bacteriology},
  volume = {200},
  number = {6},
  pages = {e00649-17},
  issn = {0021-9193},
  doi = {10.1128/JB.00649-17},
  urldate = {2023-01-26},
  abstract = {Septation in bacteria requires coordinated regulation of cell wall biosynthesis and hydrolysis enzymes so that new septal cross-wall can be appropriately constructed without compromising the integrity of the existing cell wall. Bacteria with different modes of growth and different types of cell wall require different regulators to mediate cell growth and division processes. Mycobacteria have both a cell wall structure and a mode of growth that are distinct from well-studied model organisms and use several different regulatory mechanisms. Here, using Mycobacterium smegmatis, we identify and characterize homologs of the conserved cell division regulators FtsL and FtsB, and show that they appear to function similarly to their homologs in Escherichia coli. We identify a number of previously undescribed septally localized factors which could be involved in cell wall regulation. One of these, SepIVA, has a DivIVA domain, is required for mycobacterial septation, and is localized to the septum and the intracellular membrane domain. We propose that SepIVA is a regulator of cell wall precursor enzymes that contribute to construction of the septal cross-wall, similar to the putative elongation function of the other mycobacterial DivIVA homolog, Wag31., IMPORTANCE The enzymes that build bacterial cell walls are essential for cell survival but can cause cell lysis if misregulated; thus, their regulators are also essential. The number and nature of these regulators is likely to vary in bacteria that grow in different ways. The mycobacteria are a genus that have a cell wall whose composition and construction vary greatly from those of well-studied model organisms. In this work, we identify and characterize some of the proteins that regulate the mycobacterial cell wall. We find that some of these regulators appear to be functionally conserved with their structural homologs in evolutionarily distant species such as Escherichia coli, but other proteins have critical regulatory functions that may be unique to the actinomycetes.},
  pmcid = {PMC5826036},
  pmid = {29311277},
  file = {/Users/zach/Zotero/storage/7LKT2SGF/Wu et al_2018_Characterization of Conserved and Novel Septal Factors in Mycobacterium.pdf}
}
